SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly results and forward guidance are the main focus, with traders debating whether data-center demand can offset concerns about PC demand and broader chip weakness after Intels cautious outlook. The community is split between hopes that a strong report could lift semiconductor stocks and fears that shares may fall even on a beat if guidance disappoints or market sentiment stays weak.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is drawing attention ahead of its quarterly earnings report, with traders weighing its favorable preliminary revenue and margin update against the need for confirmation, stronger forward guidance, and improved cash flow. Bulls expect a strong report to help the shares recover, while skeptics point to thin margins, cash burn, and lingering distrust of management, noting that the stock has remained weak despite the upbeat update.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Anticipation of the FDAs November 22 decision on Capricors Duchenne muscular dystrophy therapy deramiocel is driving attention, with traders debating whether its HOPE-3 upper-limb data could support approval and whether heavy short interest could amplify the move. Optimists point to physician support and recent FDA flexibility in another rare-disease case, while skeptics cite the negative advisory committee outcome and statistical concerns; approval remains uncertain.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm-election outcomes are driving the discussion, with traders debating whether a Republican showing could support DJT or a Democratic blue wave could pressure the Trump-linked stock. Some point to election-related hopes and possible short covering behind the gains, while others expect a selloff and question the companys fundamentals.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Upcoming quarterly results and guidance are the main focus, with traders split over whether strong AI-data-center demand can overcome the stocks sharp pullback, valuation concerns, and broader semiconductor de-risking. Elevated options activity reflects expectations for a large post-earnings move, but direction is disputed.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista is drawing attention ahead of its quarterly earnings report, with traders positioning for a potentially sharp move after a steep pullback. Bulls expect AI and hyperscaler networking demand to support results, while skeptics worry about capex uncertainty and the stocks history of selling off after earnings.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos post-earnings selloff is drawing attention after investors focused on softer-than-expected next-quarter revenue guidance despite solid results and accelerating daily-user growth. Bulls argue engagement and the long-term business remain strong, while bears question whether user growth can translate into revenue and justify the valuation amid AI competition concerns.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigals strong Q3 Rezdiffra growth and first profitable quarter are drawing attention as MDGL sells off sharply despite the results. Traders are divided over whether the decline reflects concerns about near-term profitability and commercial spending, or the reported whistleblower lawsuit; bulls emphasize continued patient and prescriber growth, while skeptics question the durability of profits and the drugs longer-term clinical evidence.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toasts quarterly report is driving attention: traders point to continued growth and raised full-year profit guidance, while noting an earnings-per-share miss against expectations. The community is split between optimism about the business and concern that the stock may sell off after results, as it has in past earnings periods.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers quarterly earnings beat and raised full-year outlook are driving discussion, but shares have slipped despite the results. Bulls point to growth in newer non-COVID products and cost cuts, while skeptics cite flat overall revenue, falling COVID sales, and looming patent expirations as reasons the report may not mark a durable turnaround.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AB InBev Q3 Earnings Beat Estimates on Revenue Growth & Premiumization

BUD's Q3 earnings and revenues beat estimates, fueled by premiumization, strong megabrands and digital growth, despite regional weakness and margin pressures.

Anheuser-Busch Inbev (BUD) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Anheuser-Busch Inbev (BUD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Anheuser-Busch Inbev (BUD) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

AB InBev Reports Third Quarter 2026 Results

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261028546637/en/ Regulated and inside information1 Delivering solid growth today while investing for tomorrow - our...

AB InBev's Q3 Earnings on Deck: What Surprise Awaits Investors?

BUD is poised for Q3 earnings and revenue growth, fueled by premium beer demand and brand strength, but China weakness and rising costs pose challenges.

Wall Street's Insights Into Key Metrics Ahead of Anheuser-Busch Inbev (BUD) Q3 Earnings

Get a deeper insight into the potential performance of Anheuser-Busch Inbev (BUD) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Why Anheuser-Busch Inbev (BUD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Anheuser-Busch Inbev (BUD) is a Top Momentum Stock for the Long-Term

Boston Beer's Q3 Earnings on Horizon: What Surprise Awaits Investors?

SAM is poised for Q3 earnings growth despite declining sales, as strong pricing, Sun Cruiser momentum and cost savings help offset market headwinds.

Here's Why Anheuser-Busch Inbev (BUD) is a Strong Value Stock

• Reported GAAP EPS of $1.21 up 22.22% YoY
• Reported revenue of $16.51B up 9.11% YoY
• AB InBev expects FY26 EBITDA to grow in line with its medium-term outlook of 4-8%; normalized ETR 26% to 28%, and net capital expenditure $3.5B.

AB InBev faced China volume and EBITDA declines amid a challenging industry, 3Q26 margin contraction with commodity cost headwinds, and lower United States revenue and EBITDA.

AB InBevs global premium brands grew revenue outside home markets, no-alcohol beer and Beyond Beer revenue increased, and BEES Marketplace GMV increased 45% to $1.4B.

Anheuser-Busch InBev SA/NV is a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Middle Americas, South America, EMEA, Asia Pacific, Global Export and Holding Companies, and Worldwide. The company was founded on August 2, 1977 and is headquartered in Leuven, Belgium.

Anheuser-Busch InBev SA/NV - ADR

American Spirits Losing Their Buzz? US Alcohol Drinking Hits Record Low — Booze Stocks Are Already Feeling The Pain

Equity

Bearish Sentiment

Americans are drinking less alcohol than ever before, a new survey of consumption habits by an analytics firm, Gallup, published on Wednesday, showed.The latest annual review showed that about 54% Americans reported drinking alcohol, compared with 58% in 2024 and 62% in 2023. The figure is below the previous record of 55% in 1958;&nbsp;Gallup has been tracking the metric since Americans' drinking behavior since 1939.The results are the latest warning to spirit brands selling to American consumers, who are already facing weak sales as consumers tighten their purse strings due to inflation and economic uncertainty.U.S. firms like Constellation Brands (STZ), which sells Corona beer, and The Boston Beer Company (SAM) have seen their shares slide over 20% so far this year.Bank of America recently downgraded Molson Coors Beverage's (TAP), another U.S. beer company, adding that it expects U.S. beer volumes to shrink by 4% next year, steeper than its earlier prediction of 1% decline.Major foreign liquor companies are also under pressure, as the U.S. is one of their key market. U.S.-listed shares of Johnnie Walker whiskey maker Diageo (DEO) are down 11% year-to-date, heading for their fourth straight year of stock decline.Belgium's Anheuser-Busch InBev (BUD), which sells Budweiser beer, and the Netherlands' Heineken (HEINY) are outliers, with their shares 24% and 15%, respectively, year-to-date.The Gallup survey trends indicate that drinking has been falling since the pandemic-time surge in binge drinking, and as consumers have grown more health-conscious in recent years.Fifty-three percent of Americans say moderate drinking is bad for health, up from 45% last year. Fewer U.S. drinkers are consuming alcohol regularly, with a record-low 24% saying they had a drink in the previous day and 40% reporting more than a week since their last, the highest share since 2000, the survey found."The declines in alcohol consumption does not appear to be caused by people shifting to other mood-altering substances — in particular, recreational marijuana, which is now legal in about half of U.S. states," Lydia Saad, Gallup's director of social research, said."Although marijuana use is higher today than a decade ago, it has been fairly steady over the past four years and thus doesn't appear to be a factor in people choosing not to drink alcohol."On Stocktwits,&nbsp;<a href="https://stocktwits.com/symbol/WSKY">Spirited Funds ETF Whiskey &amp; Spirits (WSKY)</a>, which exclusively covers stocks of premium alcohol companies, was 'neutral.' The sentiment for&nbsp;<a href="https://stocktwits.com/symbol/VICE">AdvisorShares Vice ETF (VICE)</a>,&nbsp;which has one-third of its portfolio&nbsp;in alcohol sectors, alongside tobacco and gaming, was 'extremely bullish.'For updates and corrections, email newsroom[at]stocktwits[dot]com.

A male enjoys a drink at a bar. A new survey shows that Americans are drinking less and more admit that it's bad for their health.

A survey by analytics firm Gallup found that 54% Americans reported drinking alcohol, compared with 58% in 2024 and 62% in 2023.

Anheuser-Busch InBev

Diageo plc

Boston Beer Co., Inc. - Ordinary Shares - Class A

Constellation Brands Inc

Spirited Funds ETF Whiskey & Spirits

Republicans keep both chambers

Republicans keep the House, lose the Senate

Republicans keep the Senate, lose the House

Democrats win both chambers

Stocktwits

Stocktwits Polls

$BUD on my list of recession winners.  
I guess no matter how broke we get, we'll always need beer, $MO smokes, and $WMT :P

“Annnnd it’s gone!”

$BUD Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.21 up 22.22% YoY
• Reported revenue of $16.51B up 9.11% YoY
• AB InBev expects FY26 EBITDA to grow in line with its medium-term outlook of 4-8%; normalized ETR 26% to 28%, and net capital expenditure $3.5B.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BUD Anheuser-Busch InBev

Fundamentals

Latest BUD News